Terrance McGuire
CIK 1117003 · last filed 2026-07-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TTGT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1000 WINTER STREET, SUITE 3350
WALTHAM, MA 02154
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEER | Director | 343,636 | $1.93 | $663.2K | $1.50M | 9 | 2026-07-30 |
| IVVD | Director | 3,170,231 | $0.59 | $1.87M | -$1.02M | 10 | 2026-05-21 |
| TECX | Director | 20,262 | $19.95 | $404.2K | -$8.55M | 2 | 2025-06-11 |
| Cyclerion Therapeutics, Inc. (CYCN) Delisted | Director | 842 | $23.52 | $19.8K | $10.32M | 9 | 2023-12-04 |
| ALEC | Director | 10,908,813 | $1.83 | $19.96M | -$3.14M | 11 | 2023-09-13 |
| Invivyd, Inc. (ADGI) Delisted | Director | 31,198 | $4.64 | $144.8K | $8.50M | 4 | 2022-06-24 |
| PULM | Director | — | $1.44 | — | $0 | 5 | 2019-05-20 |
| IRWD | Director | 142,747 | $3.50 | $499.6K | -$19.0K | 35 | 2019-04-03 |
| IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted | Director | 146,803 | — | — | $0 | 1 | 2019-03-19 |
| X4 Pharmaceuticals, Inc (ASNS) Delisted | Director | 1 | $0.08 | $0 | $5.00M | 4 | 2018-06-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 1,250 | $178.75 | $223.4K | -$25.72M | 18 | 2017-03-14 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 4,278 | $5.54 | $23.7K | -$1.21M | 2 | 2013-06-19 |
| TTGT | 10%+ Owner | 31,629 | $3.79 | $120.0K | -$240.00M | 1 | 2010-12-10 |
| DECODE GENETICS INC (DCGN) Delisted | Director | 117,516 | — | — | $0 | 3 | 2008-12-16 |
Recent Filings · Page 2 of 12
117 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-26 | IVVD | Sell (S) | −347,559 | -$164.9K | EDGAR |
| 2024-12-19 | IVVD | Sell (S) | −324,241 | -$147.8K | EDGAR |
| 2024-12-16 | IVVD | Sell (S) | −190,359 | -$103.4K | EDGAR |
| 2024-12-11 | IVVD | Sell (S) | −485,400 | -$289.4K | EDGAR |
| 2024-06-24 | — | Grant (A) | +1,157,976 | $0 | |
| 2024-06-14 | SEER | Grant (A) | +58,178 | $0 | EDGAR |
| 2024-05-31 | IVVD | Sell (S) | −112,381 | -$186.6K | EDGAR |
| 2024-05-23 | IVVD | Grant (A) | — | $0 | EDGAR |
| 2023-12-04 | Cyclerion Therapeutics, Inc. (CYCN) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2023-09-13 | ALEC | Sell (S) | −500,000 | -$3.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.